dm+d

420306005

Articles

Safety in lactation: Drugs for chronic bowel disorders

21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
Search Articles

Medicine Compliance Aid Stability

ColazideAlmirall Ltd

Almirall Ltd
Colazide
Capsules 750mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Should be stored in an airtight container.
19 January 2022

Lactation Safety Information

-
No published evidence of safety
Mesalazine, of which balsalazide is the active metabolite, has been associated with a small number of possible cases of diarrhoea in breastfed infants
Monitor infant for diarrhoea
4 August 2020